Evidence map›Paper›PMID 39075135›Full record

ArticleScientific reports2024

Dosimetric impact of stopping power for human bone porosity with dual-energy computed tomography in scanned carbon-ion therapy treatment planning.

Masashi Yagi, Yushi Wakisaka, Jun Takeno, Shintaro Kanada, Toshiro Tsubouchi, Noriaki Hamatani, Hiroyasu Maruo, Masaaki Takashina, Takayoshi Ishii, Tatsuaki Kanai and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masashi YagiDepartment of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Osaka, Japan. m.yagi@radonc.med.osaka-u.ac.jp.
Yushi WakisakaDepartment of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Jun TakenoDepartment of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Shintaro KanadaDepartment of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Toshiro TsubouchiDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Noriaki HamataniDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Hiroyasu MaruoDepartment of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Masaaki TakashinaDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Takayoshi IshiiDepartment of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Tatsuaki KanaiDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka, Japan.
Shinichi ShimizuDepartment of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
Kazuhiko OgawaDepartment of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.

Funding

Japan Society for the Promotion of Science 17K16437
6 · The paper itself

Abstract

Few reports have documented how the accuracy of stopping power ratio (SPR) prediction for porous bone tissue affects the dose distribution of scanned carbon-ion beam therapy. The estimated SPR based on single-energy computed tomography (SECT) and dual-energy CT (DECT) were compared for the femur of a Rando phantom which simulates the porosity of human bone, NEOBONE which is the hydroxyapatite synthetic bone substitute, and soft tissue samples. Dose differences between SECT and DECT were evaluated for a scanned carbon-ion therapy treatment plan for the Rando phantom. The difference in the water equivalent length was measured to extract the SPR of the examined samples. The differences for SPR estimated from the DECT-SPR conversion were small with - 1.8% and - 3.3% for the Rando phantom femur and NEOBONE, respectively, whereas the differences for SECT-SPR were between 7.6 and 70.7%, illustrating a 1.5-mm shift of the range and a dose difference of 13.3% at maximum point in the evaluation of the dose distribution. This study demonstrated that the DECT-SPR conversion method better estimated the SPR of the porosity of bone tissues than SECT-SPR followed by the accurate range of the carbon-ion beams on carbon-ion dose calculations.

Indexed as

Phantoms, ImagingRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedBone and BonesCarbonFemurHeavy Ion RadiotherapyHumansPorosityRadiometryRadiotherapy DosageCarbon

Identifiers

PMID39075135
PMCPMC11286828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.